Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026)

Iridex's (IRIX) quarterly Total Non-Current Liabilities came in at $23.1 million in Q2 2026, down 14.73% year-on-year from $27.1 million in Q2 2025, and down 3.1% quarter-over-quarter from $23.8 million in Q1 2026.

Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

Iridex's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $23.1 million for Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 14.73% year-over-year to $23.1 million in Q2 2026; TTM through Apr 2026 was $23.1 million, a 14.73% decrease from a year earlier, with the FY2026 full-year figure at $23.8 million, down 10.78% from the prior year.
  • Total Non-Current Liabilities retreated to $23.1 million in Q2 2026 per IRIX's latest filing, from $23.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $27.3 million in Q1 2024 and bottomed at $22.7 million in Q3 2023.
  • The 5-year median for Total Non-Current Liabilities is $25.3 million (2022), against an average of $25.4 million.
  • Across the five-year window, Total Non-Current Liabilities surged 139.7% in 2022 and declined 15.3% in 2023, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $25.0 million in 2022, then slipped by 1.13% to $24.8 million in 2023, then rose by 7.98% to $26.7 million in 2024, then dropped by 12.6% to $23.4 million in 2025, then fell by 1.09% to $23.1 million in 2026.
  • Per Business Quant, the three latest IRIX Total Non-Current Liabilities figures stand at $23.1 million (Q2 2026), $23.8 million (Q1 2026), and $23.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Iridex 15.93 Mn 11.33 Mn 4.74 Mn 23.10 Mn

Historic Data

Download Data
DateValue
Apr 4, 2026 23.10 Mn
Jan 3, 2026 23.84 Mn
Sep 27, 2025 23.36 Mn
Jun 28, 2025 25.22 Mn
Mar 29, 2025 27.09 Mn
Dec 28, 2024 26.72 Mn
Sep 28, 2024 27.21 Mn
Jun 29, 2024 26.70 Mn
Mar 30, 2024 27.30 Mn
Dec 30, 2023 24.75 Mn
Sep 30, 2023 22.75 Mn
Jul 1, 2023 23.46 Mn
Apr 1, 2023 24.97 Mn
Dec 31, 2022 25.03 Mn
Oct 1, 2022 26.86 Mn
Jul 2, 2022 26.19 Mn
Apr 2, 2022 26.67 Mn
Jan 1, 2022 25.36 Mn
Oct 2, 2021 25.20 Mn
Jul 3, 2021 23.62 Mn